PARKINSON'S DISEASE DEMENTIA: AT THE CROSSROADS OF α-SYNUCLEIN, TAU AND AMYLOID-β

被引:0
作者
Irwin, David [1 ]
Lee, V. [1 ]
Trojanowski, J. [1 ]
机构
[1] Univ Penn, Philadelphia, PA 19104 USA
关键词
Parkinson's disease; Dementia; Neuropathology;
D O I
10.1016/j.neurobiolaging.2014.01.070
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
引用
收藏
页码:S11 / S11
页数:1
相关论文
共 50 条
  • [41] Multiplex immunoassay measurement of amyloid-β42 to amyloid-β40 ratio in plasma discriminates between dementia due to Alzheimer's disease and dementia not due to Alzheimer's disease
    Vogelgsang, Jonathan
    Shahpasand-Kroner, Hedieh
    Vogelgsang, Rebekka
    Streit, Frank
    Vukovich, Ruth
    Wiltfang, Jens
    EXPERIMENTAL BRAIN RESEARCH, 2018, 236 (05) : 1241 - 1250
  • [42] Plasma extracellular vesicles tau and β-amyloid as biomarkers of cognitive dysfunction of Parkinson's disease
    Chung, Chen-Chih
    Chan, Lung
    Chen, Jia-Hung
    Bamodu, Oluwaseun Adebayo
    Chiu, Hung-Wen
    Hong, Chien-Tai
    FASEB JOURNAL, 2021, 35 (10)
  • [43] Longitudinal striatal dopamine transporter binding and cerebrospinal fluid alpha-synuclein, amyloid beta, total tau, and phosphorylated tau in Parkinson's disease
    Nabizadeh, Fardin
    Pirahesh, Kasra
    Ramezannezhad, Elham
    NEUROLOGICAL SCIENCES, 2023, 44 (02) : 573 - 585
  • [44] Visual Hallucinations and Amyloid Deposition in Parkinson's Disease Dementia: A Case Report
    Um, Yoo Hyun
    Kim, Tae-Won
    Jeong, Jong-Hyun
    Seo, Ho-Jun
    Han, Jin-Hee
    Hong, Seung-Chul
    Jung, Won-Sang
    Choi, Woo Hee
    Lee, Chang-Uk
    Lim, Hyun Kook
    PSYCHIATRY INVESTIGATION, 2016, 13 (03) : 364 - 369
  • [45] Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson's disease
    Haggerty, Thomas
    Credle, Joel
    Rodriguez, Olga
    Wills, Jonathan
    Oaks, Adam W.
    Masliah, Eliezer
    Sidhu, Anita
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2011, 33 (09) : 1598 - 1610
  • [46] The Mechanisms of the Roles of α-Synuclein, Amyloid-β, and Tau Protein in the Lewy Body Diseases: Pathogenesis, Early Detection, and Therapeutics
    Noguchi-Shinohara, Moeko
    Ono, Kenjiro
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (12)
  • [47] Cerebrospinal Fluid Tau/α-Synuclein Ratio in Parkinson's Disease and Degenerative Dementias
    Parnetti, Lucilla
    Chiasserini, Davide
    Bellomo, Gianni
    Giannandrea, David
    De Carlo, Claudia
    Qureshi, Mohamed M.
    Ardah, Mustafa T.
    Varghese, Shiji
    Bonanni, Laura
    Borroni, Barbara
    Tambasco, Nicola
    Eusebi, Paolo
    Rossi, Aroldo
    Onofrj, Marco
    Padovani, Alessandro
    Calabresi, Paolo
    El-Agnaf, Omar
    MOVEMENT DISORDERS, 2011, 26 (08) : 1428 - 1435
  • [48] Fibrillization of α-synuclein and tau in familial Parkinson's disease caused by the A53T α-synuclein mutation
    Kotzbauer, PT
    Giasson, BI
    Kravitz, AV
    Golbe, LI
    Mark, MH
    Trojanowski, JQ
    Lee, VMY
    EXPERIMENTAL NEUROLOGY, 2004, 187 (02) : 279 - 288
  • [49] Longitudinal striatal dopamine transporter binding and cerebrospinal fluid alpha-synuclein, amyloid beta, total tau, and phosphorylated tau in Parkinson’s disease
    Fardin Nabizadeh
    Kasra Pirahesh
    Elham Ramezannezhad
    Neurological Sciences, 2023, 44 : 573 - 585
  • [50] REM sleep behavior disorder and cerebrospinal fluid alpha-synuclein, amyloid beta, total tau and phosphorylated tau in Parkinson's disease: a cross-sectional and longitudinal study
    Nabizadeh, Fardin
    Pirahesh, Kasra
    Valizadeh, Parya
    JOURNAL OF NEUROLOGY, 2022, 269 (09) : 4836 - 4845